HHD

HHD Co., Ltd. is a specialized pharmaceutical company based in South Korea that focuses on the import, distribution, and commercialization of orphan drugs and medical devices for rare diseases. Established in 1999, the company serves as a critical bridge for global biotechnology and pharmaceutical firms looking to enter the Korean market with specialized therapies. HHD manages a diverse portfolio of products targeting metabolic disorders, genetic conditions, and other underserved medical needs. The company provides comprehensive services including regulatory affairs, market access, and specialized logistics for temperature-sensitive biologics. By partnering with international leaders in the orphan drug space, HHD ensures that Korean patients have access to life-saving treatments for ultra-rare conditions.